Navigation Links
An improved, cost-effective catalyst for water-splitting devices
Date:1/8/2014

Solar energy appears to be the only form of renewable that can be exploited at level that matches the world's growing needs. However, it is equally necessary to find efficient ways to store solar energy in order to ensure a consistent energy supply when sunlight is scarce. One of the most efficient ways to achieve this is to use solar energy to split water into hydrogen and oxygen, and get the energy back by consuming hydrogen in a fuel cell. But collecting solar energy on a large and sustainable scale means that such cells must be made from materials that are cheap, abundant, and have 10% solar‐to‐hydrogen conversion efficiency. Publishing in Nature Communications, an EPFL-led team of scientists has found a method to create a high-efficiency, scalable solar water splitting device using cheap materials.

Although one of the best means of sourcing renewable energy, solar systems cannot consistently produce adequate energy since sunlight varies from time to time and place to place. A solution to this problem is a device that can store energy in the form of hydrogen for later use, offering a consistent output over time with very little pollution.

One of the most sustainable methods of producing hydrogen is photoelectrochemical (PEC) water-splitting. Solar energy is used to break water molecules into hydrogen and oxygen through a process called "hydrogen evolution reaction". This reaction requires a catalyst, which is a chemical agent that increases its speed. In PEC water-splitting devices, a common catalyst used to split water is platinum, which is deposited on the surface of the solar panel's photocathode the solar panel's electrode that converts light into electric current.

A research team at EPFL has now found a way to make efficient solar-powered water splitting devices using abundant and cheap materials. The group of Xile Hu developed a molybdenum-sulfide catalyst for the hydrogen evolution reaction, and the gr
'/>"/>

Contact: Nik Papageorgiou
n.papageorgiou@epfl.ch
Ecole Polytechnique Fdrale de Lausanne
Source:Eurekalert

Page: 1 2

Related biology news :

1. Molecular Velcro may lead to cost-effective alternatives to natural antibodies
2. A cost-effective way toward personalized cancer drugs
3. Researchers develop rapid, cost-effective early detection method for organ transplant injury
4. Cost-effective: Universal HIV testing in India
5. A new cost-effective genome assembly process
6. Cost-effective production of infrared lenses
7. Rice scientists ID new catalyst for cleanup of nitrites
8. New catalyst could cut cost of making hydrogen fuel
9. Diamond catalyst shows promise in breaching age-old barrier
10. Metal-free catalyst outperforms platinum in fuel cell
11. Mysterious catalyst explained
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... poisonous frog was recently discovered in a remote mountainous ... supported by the Conservation Leadership Programme (CLP). The new ... given the name the ?golden frog of Supat. ... to several other common species in the area. However, ...
... of highly organized epithelial cells line all the cavities ... the movement of liquids,and cells in the body organs. ... serve as a barrier against cancer, according to a,study ... week in,the online edition of the Proceedings of the ...
... today by the Health Department shed new light on the ... who responded to the World Trade Center disaster on September ... Health Registry, show that 3.6% of the 25,000 rescue and ... working at the site. That rate is 12 times what ...
Cached Biology News:Cells united against cancer 2Survey finds elevated rates of new asthma among WTC rescue and recovery workers 2Survey finds elevated rates of new asthma among WTC rescue and recovery workers 3
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation introduces ... comprehensive line of analytical laboratory equipment. With optimized features, such as PTFE-coated contact ... chemically resistant and maintenance-free solution for a broad range of vacuum filtration applications. ...
(Date:7/31/2015)... , July 31, 2015 In ... resources that help them drive positive health outcomes, ... vital source of patient care in their communities. ... annual tradeshow and conference, AmerisourceBergen announced a new ... Pharmacy Services Administration Organization and help independent pharmacies ...
(Date:7/31/2015)... ... 31, 2015 , ... Global Resorcinol Market 2015-2019 is a ... the global resorcinol industry. The report highlights the various growth prospects and the ... analysis of primary and secondary inputs from the existing players of the resorcinol ...
(Date:7/31/2015)... July 31, 2015 China Cord Blood Corporation ... leading provider of cord blood collection, laboratory ... services, today announced that the Company has filed its ... and Exchange Commission. The filed Form 20-F includes audited ... 2015. The Form 20-F can be accessed by visiting ...
Breaking Biology Technology:Sterlitech Launches New Line of Vacuum Pumps 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4China Cord Blood Corporation Files Its Annual Report on Form 20-F 2
... Research conducted at The,Walter and Eliza Hall ... licensing agreement signed between Australian biotechnology company,Bionomics, ... Under the Development and Licensing Agreement, Merck ... multiple sclerosis (MS) and other autoimmune,conditions. These ...
... -- WuXi PharmaTech (NYSE:,WX), a leading pharmaceutical, biotechnology ... operations in China and the United,States, today announced ... Vice President,of Human Resources., (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ... Mr. Zhu worked as Head of Asia Human,Resources ...
... Antonio (June 30, 2008) Researchers at The University of ... Infectious Diseases and The University of Texas Health Science Center ... to play a role in controlling the early infectious process ... agent that is the cause of tularemia. The findings will ...
Cached Biology Technology:MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR 2UTSA/UTHSCSA publish results on bio-threat agent 2